Skip to content

Scholar Rock SRRK Interest Paid

Interest Paid at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.16M0.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$3.63M
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$140K+35.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.75K
Cytokinetics logo
CytokineticsCYTK
$1.59M-83.6%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$6.14B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's interest paid?
Scholar Rock (SRRK) reported interest paid of $2.37M in Q1 2026.
How has Scholar Rock's interest paid changed year-over-year?
Scholar Rock's interest paid increased by 57.9% year-over-year, from $1.5M to $2.37M.
What is the long-term trend for Scholar Rock's interest paid?
Over 4 years (2021 to 2025), Scholar Rock's interest paid has grown at a 30.6% compound annual growth rate (CAGR), from $2.08M to $6.07M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.